FDA Warning Letter — Exxon

Case 689129 — FEI 3031734294

The FDA took a Warning Letter action against Exxon on Jul 25, 2024 (Newark, NJ). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Exxon
Date
Jul 25, 2024
Fiscal Year
2024
Product Type
Tobacco
Center
CTP
Location
Newark, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.